Journal of Natural Products · 2019 · 41 citations · 34 references
Life SciencesBotanyPharmacologyInflammationInnate ImmunityPlant BiochemistryAnti-inflammatory PharmacologyFlavonoid BiosynthesisInflammation PharmacologyMedicinal PlantsNitric OxideNitric Oxide ProductionPcsk9 InhibitorsProprotein Convertase Subtilisin/kexin Type 9 InhibitionProprotein Convertases
Seven new prenylated flavonoids (1–7) and one new prenylated phenylpropiophenone (8) were isolated from roots and rhizomes of Sophora tonkinensis, along with nine known compounds (9–17). The structures 1–8 were elucidated by spectroscopic data analysis and comparison with reported values. Compounds 8 and 12 (7-methoxyebenosin) showed inhibitory activities against nitric oxide production in lipopolysaccharide-induced RAW264.7 cells, with IC50 values of 8.1 and 6.2 μM, respectively. They also significantly lowered expression of CSF2, TNF, and IL-1β. Lonchocarpol A (10) and erybraedin D (16) at concentrations of 20 μM downregulated proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA expression in HepG2 cells. Moreover, erybraedin D (16) inhibited PCSK9 protein synthesis (IC50 7.8 μM), while simultaneously activating AMP-activated protein kinase and acetyl-CoA carboxylase.
34
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès et al. · Nature Genetics · 2003 · 3K citations
Antiviral Matrine-Type Alkaloids from the Rhizomes of <i>Sophora tonkinensis</i>
Qi-Ming Pan, Yuhuan Li, Jing Hua et al. · Journal of Natural Products · 2015 · 103 citations